STAT3 variants as a rheostat of immune tolerance
STAT3 variants as a rheostat of immune tolerance
批准号:
10328097
负责人:
Mark S Anderson
金额:
$176.58万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-17 至 2027-01-31
关键词:
Animal ModelAutoantibodiesAutoimmune DiabetesAutoimmunityCRISPR/Cas technologyCell modelCellsChildhoodClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsComplexCritical PathwaysDefectDiagnosisDiseaseEpistatic GeneFunctional disorderGenetic EngineeringGenetic ModelsGrantHealthHumanHuman GeneticsImmuneImmune System DiseasesImmune ToleranceImmune systemInflammationInsulin-Dependent Diabetes MellitusLeadMapsMediatingMethodsModelingMusMutationOutcomePathogenesisPatientsPersonal SatisfactionPhage ImmunoPrecipitation SequencingPopulationProcessProgram Research Project GrantsResourcesSTAT3 geneSamplingSignal TransductionSkinSyndromeT-LymphocyteVariantWorkbasecentral tolerancegain of functiongene interactiongenetic variantgenome editingimprovedmouse modelnovelperipheral toleranceprogramsrepairedresponsesynergismtherapy developmenttreatment strategy
中文摘要
项目摘要/摘要(总体)
免疫系统的失调可能会对健康和福祉造成严重后果。尽管这是
通常情况下,这是一个复杂的过程,人类遗传学的最新进展使单基因的鉴定成为可能
与免疫失调密切相关的变异。在这里,在这个项目中,授予三个
互补的团队将共同努力,进一步揭示杂合突变是如何导致收益的
STAT3基因的功能活性缺失(GOF)与疾病的易感性很强。此外,通过我们的努力,
我们希望找到潜在的新方法来扭转这一缺陷。这项计划项目将有三个高度
由梅根·库珀博士、马克·安德森博士和亚历克斯·马森博士领导的协作和互动项目
以及两个科学核心。资助金的主要主题是:
1.更精细地分析STAT3 GOF患者的免疫细胞功能障碍
2.使用最先进的动物建模方法询问触发过程中的STAT3 GOF突变
皮肤炎与1型糖尿病
3.利用CRISPR/CAS9最先进的方法询问STAT3 GOF功能障碍
4.人类细胞STAT3基因缺陷修复的建模方法
这项工作的长期目标是提高我们对STAT3如何充当可调项的理解
控制免疫耐受和免疫失调的变阻器。这些研究的结果将有助于进一步
加深对自身免疫性炎症的认识,帮助改进自身免疫性炎症的治疗和治疗方法
诊断。
英文摘要
Project Summary/Abstract (Overall)
Dysregulation of the immune system can have severe consequences on health and wellbeing. Although this is
often a complex process, recent progress in human genetics has allowed for the identification of single gene
variants that are strongly associated with immune dysregulation. Here, in this program project grant three
complementary teams will be working together to further unravel how heterozygous mutations that lead to gain
of function activity (GOF) of the STAT3 gene can strongly predispose to disease. Moreover, through our efforts
we hope to discover potential new methods to reverse this defect. This program project will have three highly
collaborative and interactive projects headed by Drs. Megan Cooper, Mark Anderson, and Alex Marson
along with two scientific cores. The major themes of the grant are:
1. More refined analysis of the immune cell dysfunction in STAT3 GOF patients
2. Using state of the art animal modeling approaches to interrogate STAT3 GOF mutations in triggering
skin inflammation and type 1 diabetes
3. Utilizing state of the art CRISPR/Cas9 methods to interrogate STAT3 GOF dysfunction
4. Modeling methods to genetically repair defective STAT3 in human cells
The long-term objectives of this work are to improve our understanding of how STAT3 can serve as a tunable
rheostat to control immune tolerance and immune dysregulation. Results of these studies will help further
refine our understanding of autoimmunity inflammation and help improve methods for its treatment and
diagnosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10328098
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Project 2: STAT3 as a trigger for T1D
-
批准号:10576386
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10630946
-
项目类别:
-
资助金额:$46.85万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10502136
-
项目类别:
-
资助金额:$64.67万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Project 2: STAT3 as a trigger for T1D
-
批准号:10328102
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Core A: Mouse Core
-
批准号:10328099
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10503923
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10683384
-
项目类别:
-
资助金额:$66.63万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Core A: Mouse Core
-
批准号:10576378
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
STAT3 variants as a rheostat of immune tolerance
-
批准号:10576375
-
项目类别:
-
资助金额:$176.56万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Administrative Core
-
批准号:10576377
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Immune Tolerance Network
-
批准号:10625931
-
项目类别:
-
资助金额:$684.91万
-
财政年份:2021
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10179371
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10413178
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10020398
-
项目类别:
-
资助金额:$95.13万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10762177
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance
-
批准号:9106605
-
项目类别:
-
资助金额:$57.84万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Core A - Animal core
-
批准号:9151386
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Project 1 - Central thymic tolerance as a major checkpoint in T1D
-
批准号:9151388
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Disruption of T cell tolerance in type 1 diabetes
-
批准号:9291418
-
项目类别:
-
资助金额:$162.91万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
海外基金